PM360

AUGUST 26, 2024

Now, precision medicine needs an overhaul. During the period from 2008 through 2020, the number of precision medicines in the US increased from 5 to 285. How can a newly expanded definition of precision medicine help? Today, they have implemented the precision medicine approach across 90% of their portfolio.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

European Pharmaceutical Review

NOVEMBER 10, 2023

Novo Nordisk has announced plans to invest over 42 billion Danish kroner (nearly £5 billion) starting in 2023, to expand its manufacturing facilities in Kalundborg, Denmark. According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging.

Manufacturing 111

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 111

European Pharmaceutical Review

AUGUST 29, 2024

The Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG) Investment Programme is a joint initiative between the Department of Health and Social Care (DHSC), NHS England and the Association of the British Pharmaceutical Industry (ABPI).

Government 59

Government Pharma Competition Medicine 59

European Pharmaceutical Review

SEPTEMBER 26, 2022

Martin Shanahan, CEO of IDA Ireland declared: “It is a very significant day for a plant that already has a long and proud record of pharmaceutical manufacturing and innovation. Earlier this year, AbbVie was named Best Workplace for Women and ‘Biopharma Company of the Year’ at the latest Irish Pharma Industry Awards.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

European Pharmaceutical Review

DECEMBER 18, 2023

Additionally, in October, EPR shared Phase III trial data for the type 1 diabetes treatment TZIELD (Teplizumab), which suggested that the medicine could slow disease progression. The year 2023 also brought much advancement in the Alzheimer’s space for the pharmaceutical industry.

Manufacturing 98

Manufacturing Food and Drug Administration Medicine Pharmaceutical manufacturing 98

European Pharmaceutical Review

APRIL 11, 2024

Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. megatonnes in the same year, and the increased demand and complexity of medicines since then will only have swollen this figure. 1 That’s more than the automotive sector, which released 46.4

Manufacturing 105

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 105

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical wholesalers act as intermediaries between pharmaceutical manufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Worldwide sourcing and drop-ship of orphan medicines, and. GDP and GMP advisory. Warehousing and logistics services.

Leads 52

Leads Pharmaceutical Customer Relationship Management Retail 52

Pharma Leaders

MAY 8, 2023

The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticals’ pharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. The inspection will allow the company to commence commercial operations at the three-storey, 84,000ft² manufacturing facility.

Manufacturing 52

Manufacturing Food and Drug Administration FDA Pharmaceutical manufacturing 52

pharmaphorum

DECEMBER 16, 2022

She continued to say that the stockpiling of vaccines and treatments in richer nations had left other nations without access to lifesaving medicine. This could mean that the pharma companies would need to disclose pricing and contractual terms for pandemic products, as well as mechanisms to transfer technology and expertise.

Distribution 96

Distribution Pharmaceutical manufacturing Manufacturing Pharmaceutical 96

Pharmaceutical Technology

DECEMBER 19, 2022

Pierre Socha, partner at Amadeus Capital Partners, London, UK, predicts that larger pharmaceutical companies may have similar interests. Most pharmas will buy biotech companies or smaller pharma groups for the quality of their clinical assets and the drugs on their developments,” he says.

Pharmaceutical 69

Pharmaceutical Manufacturing Medicine Government 69

pharmaphorum

NOVEMBER 25, 2022

The purpose behind this new Biotech Centre of Excellence is not just as an advancement into the production of biological medicines for Chiesi; it is, rather, an advancement for Italy as a whole. So, the Biotech Centre of Excellence will project the group towards the future of medicine and science.

Pharmaceutical 98

Pharmaceutical Manufacturing Medicine Competition 98

pharmaphorum

NOVEMBER 1, 2022

The two venerable Indiana institutions – Lilly headquartered in Indianapolis and Purdue in nearby West Lafayette – have been working together for many years, collaborating on life sciences research in areas such as new delivery systems for injectable medicines and predictive models for clinical research.

Manufacturing 52

Manufacturing Biopharma Medicine Pharmaceutical manufacturing 52

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Marketing 69

Marketing Pharmaceutical Leads Manufacturing 69

Contrarian Sales Techniques

FEBRUARY 26, 2023

There was an article that examine the market for generic medicines in the Malaysia, following the introduction of the first generic patent in 2010 and the introduction of generic patent law in 2012. The market for medicines in Malaysia is divided between private clinics, private clinics, and pharmacies.

Pharmaceutical 52

Pharmaceutical Medicine Government Manufacturing 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

The information contained within the download document is useful for pharmaceutical executives, drug development officers, product marketing managers, marketing executives, medical representatives, senior procurement executives, pharma packaging development specialists, and any other individual involved in pharmaceutical commercial packaging.

Leads 40

Leads Marketing Pharmaceutical Medicine 40

PM360

AUGUST 9, 2022

Pharma Manufacturer Solutions. GM of Manufacturer Solutions. 1 GoodRx’s partnerships with pharma manufacturers and other key stakeholders in the healthcare industry enable them to offer discounts which have helped patients fill at least 80 million prescriptions that they otherwise could not afford. References: 1.

Prescription 105

Prescription Medical Patients Side effects 105

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Pharmaceutical 52

Pharmaceutical Leads Marketing Manufacturing 52

Pharma Marketing Network

JUNE 11, 2020

RJ Lewis (EHS): Hello, this is RJ Lewis and we’re back for Episode 2 with John Mack and Don Langsdorf, and we’re talking about the rebirth of Pharma Marketing and Pharma Guy. So, you continue with Pharma Marketing news. Where do you see it going? RJ Lewis (EHS): So, thanks for that question. That’s our vision.

Pharma 52

Pharma Marketing Media Healthcare 52

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Estimated Cancer Risks Associated with Nitrosamine Contamination in Commonly Used Medications. Int J Environ Res Public Health.

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

Pharmaceutical Technology

DECEMBER 6, 2022

Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceutical manufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).

Manufacturing 52

Manufacturing Pharmaceutical Pharmaceutical manufacturing Safety 52

pharmaphorum

JULY 28, 2022

Supply chain shortages have dominated headlines for several months, and the pharma industry has been no exception. The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceutical manufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems.

Pharma 111

Pharma FDA Consulting Manufacturing 111

Pharmaceutical Technology

JUNE 7, 2023

The funding will support the new production plant and distribution hub, which is aimed at enhancing access to high-quality medicines in Africa. The manufacturing site will be completed in three phases and will produce anti-bacterial medicines and anti-malarial drugs.

Manufacturing 96

Manufacturing Pharma Distribution Pharmaceutical products 96

PM360

JUNE 26, 2023

The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. For pharmaceutical manufacturing, many of these processes are subject to good manufacturing practice (GxP) and oversight by regulatory bodies. drug manufacturers to continue producing generic drugs.

Manufacturing 97

Manufacturing Pharmaceutical manufacturing Pharma Management 97

Medico Reach

FEBRUARY 8, 2023

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing.

Pharma 52

Pharma Medicine Marketing Prospecting 52

European Pharmaceutical Review

MAY 31, 2023

The inventory position of 28 major pharmaceutical manufacturers in 2022 has been revealed in an annual report. Analysis explored the impact of macro-trends on inventory management from corporate reports of Big Pharma companies including Merck, AstraZeneca and Pfizer.

Management 111

Management Pharma Pharmaceutical manufacturing Medicine 111

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Kerry, Ireland.

Pharmaceutical manufacturing 104

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 104

Pharmaceutical Technology

MARCH 22, 2023

Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report. For innovative medicines, this share was 77%. Moreover, US Pharmacopeia issued the first-ever Medicine Supply Map to find and quantify risks in upstream pharmaceutical supply chains across the country.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Government Pharmaceutical 105

European Pharmaceutical Review

JULY 5, 2024

This follows publication of its Manifesto , which detailed recommendations such as increasing patient access to new treatments through clinical trials and enhancing the pharmaceutical manufacturing in the UK. EU pharmacovigilance is stronger with the UK, and UK research is stronger with the EU.”

Pharma 98

Pharma Government Safety Medicine 98

PM360

NOVEMBER 14, 2023

General Medicines at Sanofi. “We Through our Pharma Manufacturer Solutions offering, GoodRx has worked with 19 of the top 20 pharmaceutical manufacturers 1 to deliver savings options directly to relevant patients. References: 1.

Retail 52

Retail Sales Pharmaceutical manufacturing Insurance 52

Pharmaceutical Technology

FEBRUARY 15, 2023

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised. Cold chain shipments are particularly vulnerable.

Pharma 52

Pharma Pharmaceutical Manufacturing Medicine 52

European Pharmaceutical Review

JULY 21, 2023

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. What types of medicinal products are in short supply and why?

Pharmaceutical 98

Pharmaceutical Food and Drug Administration Transportation Manufacturing 98

PM360

DECEMBER 20, 2023

Thus, this article aims to outline the healthcare system and key market access pathways that are opening in China for pharmaceutical products, including vaccines. Additionally, it will delve into the current trends and challenges that pharma companies need to consider when devising successful market access strategies for this unique market.

Marketing 105

Marketing Insurance Medical Manufacturing 105

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 78

Manufacturing Marketing Pharma Distribution 78

European Pharmaceutical Review

APRIL 9, 2025

The architecture has been developed through the Digital Membership consortium at CPIs Medicines Manufacturing Innovation Centre. CPI’s new Digital Architecture follows the organisation’s announcement in February of the launch of a new digital process manufacturing centre in Scotland.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 52

World of DTC Marketing

MARCH 15, 2021

SUMMARY : Big pharma is a big business, and nothing motivates big companies more than the potential to earn a lot of money on new products. Big pharma is a huge business with profits that top almost every other industry. Big pharma is a huge business with profits that top almost every other industry.

Pharma 180

Pharma Sales Manufacturing Retail 180

European Pharmaceutical Review

FEBRUARY 20, 2025

The pharmaceutical industry relies on a globally integrated supply chain to source raw materials, active pharmaceutical ingredients (APIs), and finished medicines. 1 Here, we explore the potential impact of tariffs on pharmaceutical supply chains, pricing, investment and industry strategy.

Pharmaceutical 20

Pharmaceutical Manufacturing Medicine Pharmaceutical manufacturing 20